Huasheng Gene

Shenzhen Huasheng Biotechnology, operating under the brand Huasheng Gene, is a prominent precision medicine and genomics company based in China. Founded in 2016, the company specializes in the development and clinical application of high-throughput sequencing (NGS) and liquid biopsy technologies. Its primary focus is on oncology, providing comprehensive genetic testing services for cancer screening, therapy selection, and minimal residual disease (MRD) monitoring. Huasheng Gene integrates large-scale genomic data with bioinformatic platforms to deliver actionable insights for personalized patient care. The company operates state-of-the-art clinical laboratories and actively collaborates with major medical institutions to advance genomic medicine standards in Asia.